Showing results (141-150 of 154) with videos related to
Sort By:
Pageof 16
Nature|February 5, 2021
SARS-CoV-2 evolution during treatment of chronic infectionSteven A Kemp, Dami A Collier, Rawlings P Datir, et al.Science Immunology|August 12, 2022
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutationsWilliam Rae, John M Sowerby, Dorit Verhoeven, et al.United European Gastroenterology Journal|July 11, 2025
Assessment of PredictSURE IBD Assay in a Multinational Cohort of Patients With Inflammatory Bowel DiseaseDahham Alsoud, Nurulamin M Noor, Lea Ann Chen, et al.Nature|March 11, 2021
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.Immunity|May 29, 2021
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild diseaseLaura Bergamaschi, Federica Mescia, Lorinda Turner, et al.Brain : a Journal of Neurology|September 6, 2022
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responsesEdward J Needham, Alexander L Ren, Richard J Digby, et al.Science (New York, N.Y.)|May 25, 2019
Germline selection shapes human mitochondrial DNA diversityWei Wei, Salih Tuna, Michael J Keogh, et al.The Lancet. Gastroenterology & Hepatology|February 25, 2024
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trialNurulamin M Noor, James C Lee, Simon Bond, et al.Nature Communications|December 15, 2020
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case reportMatthew S Buckland, James B Galloway, Caoimhe Nic Fhogartaigh, et al.Nature|February 1, 2022
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicityBo Meng, Adam Abdullahi, Isabella A T M Ferreira, et al.Pageof 16